PT Darya-Varia Laboratoria TbkISX:DVLA 73 Dividend Yield % is 6.77% as of Jun. 28, 2026, which is 34% above its 10-year median of 5.06. GuruFocus rates ISX:DVLA with a GF Score™ of 73/100 and a GF Value™ of Rp1,840.45 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 517 Drug Manufacturers companies, PT Darya-Varia Laboratoria Tbk ranks better than 96.71% on this metric.
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of PT Darya-Varia Laboratoria Tbk is 0.88, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of PT Darya-Varia Laboratoria Tbk was 0.94. The lowest was 0.26. And the median was 0.74.
During the past 3 years, the average Dividends Per Share Growth Rate was -2.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -0.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 7.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of PT Darya-Varia Laboratoria Tbk was 65.70% per year. The lowest was -9.80% per year. And the median was 3.45% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:DVLA vs ZTS, UTHR, VTRS: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Darya-Varia Laboratoria Tbk Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
PT Darya-Varia Laboratoria Tbk Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
IDR 41.000000
2025-10-30
2025-10-31
2025-11-17
Cash Dividend
semi-annually
IDR:IDR 1.000000
IDR 67.000000
2025-06-30
2025-07-01
2025-07-17
Cash Dividend
semi-annually
IDR:IDR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Dividend Yield % of 6.77% as of Jun. 28, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. This is 34% above median its historical median of 5.06. Over the past decade, PT Darya-Varia Laboratoria Tbk's Dividend Yield % has ranged from 1.30 to 8.71. According to the industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #17 out of 517 companies in the Drug Manufacturers industry, placing it in the top 3.3%.
Is PT Darya-Varia Laboratoria Tbk's Dividend Yield % too high?
PT Darya-Varia Laboratoria Tbk's current Dividend Yield % of 6.77% is 34% above median its 10-year median of 5.06. Over the past 10 years, this metric has ranged from a low of 1.30 to a high of 8.71. The Drug Manufacturers industry median Dividend Yield % is 2.06. PT Darya-Varia Laboratoria Tbk's value of 6.77% is 228.6% above this industry median. Based on the distribution chart, PT Darya-Varia Laboratoria Tbk ranks #17 out of 517 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #17 out of 517 companies for Dividend Yield %. This places PT Darya-Varia Laboratoria Tbk in the top 3% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.06. PT Darya-Varia Laboratoria Tbk's value of 6.77% is 228.6% above this benchmark. Historically, PT Darya-Varia Laboratoria Tbk's own Dividend Yield % has ranged from 1.30 to 8.71 over the past decade. While the company's 10-year median is 5.06 vs. the industry median of 2.06, PT Darya-Varia Laboratoria Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.06, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Darya-Varia Laboratoria Tbk's current Dividend Yield % of 6.77% is 228.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Darya-Varia Laboratoria Tbk's current Dividend Yield % is 6.77%, which is 34% above median its own 10-year median of 5.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,840.45, compared to a current price of Rp1,595.00 — trading 13.3% below its estimated fair value. The current Dividend Yield % is 6.77%, which is 34% above median its 10-year median of 5.06 and 228.6% above the Drug Manufacturers industry median of 2.06. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Dividend Yield % is 6.77% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued.
The current stock price of Rp1,595.00 is trading 13.3% below its estimated GF Value™ of Rp1,840.45.
GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.
Key valuation signals for ISX:DVLA:
Dividend Yield %: 6.77% (34% above median its 10-year median of 5.06)
GF Value™: Rp1,840.45 vs. price of Rp1,595.00 (13.3% below fair value)
Industry Position: 228.6% above the Drug Manufacturers median (#17 of 517)
No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Darya-Varia Laboratoria Tbk Business Description
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
73GF Score
Get the complete analysis for ISX:DVLA
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DVLA has been successfully added to your 
